Cosmos Health Inc.
Wholesale drugs, proprietaries & druggists’ sundries10 peers
- Last sale
- Nov 12, 2026 · -12.75%
- Market cap
- $20.80M
- 100.63M shares
- Filings
- 640
Q2 2026+19.9% FY25 yoy
Q2 2026N/M FY25 yoy
Q2 2026N/M FY25 yoy
Q2 2026derivedN/M FY25 yoy
Q2 2026N/M FY25 yoy
Q2 2026+127.1% FY25 yoy
- $20.80M
- —
- 0.3×
- 1.0×
- -47.75%
- —
Twelve months to Jun 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $65,271,815 | reported | |
| FY 2024 | 2024-12-31 | $54,426,402 | reported | |
| FY 2023 | 2023-12-31 | $53,376,874 | reported | |
| FY 2022 | 2022-12-31 | $50,347,652 | reported | |
| FY 2021 | 2021-12-31 | $56,239,667 | reported | |
| FY 2020 | 2020-12-31 | $55,406,337 | reported | |
| FY 2019 | 2019-12-31 | $39,676,385 | reported | |
| FY 2018 | 2018-12-31 | $37,083,882 | reported | |
| FY 2017 | 2017-12-31 | $30,013,379 revised | reported | |
| FY 2016 | 2016-12-31 | $6,755,436 | reported | |
| FY 2015 | 2015-12-31 | $533,802 | reported | |
| FY 2014 | 2014-12-31 | $7,639,022 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2024 | — | $0.00 | $0.00 | — | 27.28M sh | +55.0% | — |
| FY2023 | — | $100.45K | $100.45K | — | 17.61M sh | +65.8% | — |
| FY2021 | — | $376.86K | $376.86K | — | 17.54M sh | +9.2% | — |
| FY2020 | — | $200.00K | $200.00K | — | 16.07M sh | +20.8% | — |
Segments
Segments
LineFY2025ShareChange
Wholesale$59.32M91%+15.0%
Nutraceuticals and Pharmaceuticals$4.26M6.5%+116.7%
Pharma manufacturing$1.69M2.6%+95.2%
Other$1.23K0.0%—
Total$65.27M
Wholesale drugs, proprietaries & druggists’ sundries
Cosmos Health Inc. is the 6th largest of the 11 covered companies the SEC files under this code, by revenue. SIC 5122
CompanyRevenueGrowthNet marginMarket cap
MCKMcKesson Corp$403.4B12.4%1.2%$124.3BCORCencora, Inc.$321.3B9.3%0.5%$66.7BCAHCardinal Health Inc$254.2B14.2%0.7%$64.3BHLFHerbalife Ltd.$5.0B0.9%4.5%$1.6BNUSNU Skin Enterprises, Inc.$1.5B14.3%10.8%$195.7M
COSMCosmos Health Inc. (this company)$65.3M19.9%29.3%$20.8M
MEDSDataMeds AI, Inc.$23.3M28.7%433.9%$4.1MSTEKStemtech Corp$2.9M43.1%140.7%$1.6MESYNEnerSyn Global Inc.$866.9K30.8%303.4%$46.4MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Cosmos Health Inc. · CIK 1474167 · Engraved from SEC EDGAR